|Day Low/High||20.80 / 23.90|
|52 Wk Low/High||13.64 / 176.65|
There are several reasons why the shares were trading higher.
Upside - +90% (FDA grants Regenerative Medicine Advanced Therapy designation to SkinTE) - +37% (earnings, guidance) - +23% (Emergent Fidelity Technologies discloses 7.6% stake; crypto stocks higher as token prices and Tether stabilize) - +20% (earni...
Don't expect AFRM to rally for long or go very far.
The painful decline of the fintech stock may finally be over.
Markets were so green Wednesday, it felt like somebody knew something.
A rally in the shares could occur in the short run, but without a strong base pattern there could be weakness down the line.
Here we'll look at the GlobalX Millennial Consumer exchange-traded fund, and see how it keeps score.
AFRM could make an oversold bounce of $10 to $20, but let's look at the trend as a Real Money subscriber asks about the stock.
Expecting recent trends to continue -- and not looking further into the past for parallels -- has driven a lot of questionable behavior in 2021 from both retail and institutional investors.
In my Diary I cautioned about Affirm Holdings in early December. I should have shorted it: Source: The Divine Ms M
A brokerage firm had cautionary comments about Affirm Holdings and the "Buy Now Pay Later" business. I shared my concerns about the space earlier in the month: Dec 01, 2021 ' 08:05 AM EST DOUG KASS The Threat of Buy Now Pay Later (BNPL) * Will the ...
* Will the collapse in the share price of a leading Australian BNPL company presage weakness in the U.S. in 2022? * When a hyper growth credit product is not funded by core deposits - problems typically emerge * For now the credit cycle is benign - ...
Energy prices have turned out to be the primary driver for what now appears to be 'out of control' consumer-level prices.
Here's what to do with your longs.
I'm making a few new buys but am not moving too quickly.
In addition to the sharp turn in Tesla, other high-beta high PE names have lost their momentum.
Growth Stocks led the market on Monday, but breadth was negative as small-caps lagged.
Market volatility could spike in late November/early December just as liquidity walks away. Keep that in mind.
We're also setting a second price target for shares of the online payments company.
With the quarter ending on Thursday, there will be pressure on fund managers to run prices back up.
The fundamental story here is strong on AFRM.
* We remain in a 'Bull Market In Complacency' * There is certainty and precision of the bullish consensus despite a wide range of possible market and economic outcomes - many of which are adverse and market unfriendly * A deeper than expected (and "...
Here's what I'm risking.
Aggressive traders could add to longs on available weakness.
All life, all learning, from parenting to aging to investing is about adaptation -- the ability to evolve.
The spending spree on BNPL could be adding more risk later for investors.
One day, either the Modern Monetary Theorists will be right, or the fiscal hawks will prove correct. Count me with the hawks.
The charts are more positive now.
Here are the stocks to watch as the pandemic throws us a curve-ball.